John is a Tarceva® patient.

Tarceva® (erlotinib) is prescribed for patients with advanced-stage non-small cell lung cancer (NSCLC) who have received at least one previous chemotherapy regimen. Tarceva is not intended to be used at the same time as chemotherapy for NSCLC.